Cadence raises $100 million to make AI chronic care pay like infrastructure
Chris Altchek's second act has a $1.2 billion valuation, but the harder test is proving Medicare savings at health-system scale.
By Ryan Merket · Published
Primary source: Forbes
Why it matters
Cadence is testing whether healthcare AI can become reimbursed infrastructure for chronic care, not just another workflow tool sold into hospitals.
Chris Altchek's Cadence disclosed a $100 million funding round led by Spark Capital, putting a $1.2 billion valuation on a company trying to turn chronic disease management into an AI-enabled operating layer for health systems, Forbes reported Tuesday.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.